Indazole benzimidazole compounds
US7642278B2 · kind B2 · utility
91Cited by
4References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 27, 2005 |
| Grant date | Jan 5, 2010 |
| Priority date | — |
| Expiry date | Mar 16, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D403/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Organic compounds having the structure I are provided where the variables have the values described herein.A method of inhibiting c-ABL in a patient includes administering an effective amount of a compound of structure I, a tautomer of the compound, a pharmaceutically acceptable salt of the compound, or a pharmaceutically acceptable salt of the tautomer to the patient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.